Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregabalin for pain and sleep quality in hospitalized burn patients
IRCT20241025063491N1Phase 3Completed
- Sponsor
- Yasouj University of Medical Sciences
- Start
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in burn injury comparing Pregabalin with Placebo (2 arms). Primary endpoints: Subjective sleep quality, Sleep latency and 6 more. Started Oct 2024; status: completed.
02
Drugs
pregabalin
03
Conditions
burn injury
Beyond the preview
Go deeper on IRCT20241025063491N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20241025063491N1.